FGF2 and hepatocellular carcinoma: Together, these findings support our hypothesis that inhibition of FGFR and VEGFR by treatment with Rego induces bFGF secretion which represents a predictive biomarker in Rego-resistant HCC cells but not in Sora-resistant ones.